Filtered By:
Management: Healthcare Costs

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 274 results found since Jan 2013.

Does informal care impact utilization of healthcare services? Evidence from a longitudinal study of stroke patients
Publication date: Available online 5 November 2014 Source:Social Science & Medicine Author(s): Aleksandra Torbica , Stefano Calciolari , Giovanni Fattore Understanding the interplay between informal care and formal healthcare is important because it sheds light on the financial implications of such interactions and may result in different policies. On the basis of a major database on 544 Italian stroke patients enrolled in the period 2007-2008, we investigated whether the presence of a potential caregiver and the amount of informal care provided influences the use and the costs of healthcare services, and in part...
Source: Social Science and Medicine - November 11, 2014 Category: Psychiatry & Psychology Source Type: research

Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
Atrial fibrillation (AF) is the most common heart arrhythmia. Untreated AF incurs a considerable burden of stroke and associated healthcare costs. Asians have AF risk factors similar to Caucasians and similarly increased risk of AF-related stroke; however, with a vast and rapidly aging population, Asia bears a disproportionately large disease burden. Urgent action is warranted to avert this potential health crisis. Antithrombotic therapy with oral anticoagulants is the most effective means of preventing stroke in AF and is a particular priority in Asia given the increasing disease burden.
Source: International Journal of Cardiology - March 26, 2015 Category: Cardiology Authors: Chen-Huan Chen, Mien-Cheng Chen, Harry Gibbs, Sun U. Kwon, Sidney Lo, Young Keun On, Azhari Rosman, Nijasri C. Suwanwela, Ru San Tan, Louie S. Tirador, Andreas Zirlik Tags: Review Source Type: research

Effectiveness of dry needling for upper extremity spasticity, quality of life and function in subacute phase stroke patients.
CONCLUSION: The addition of a specific DDN treatment to a standard physiotherapy treatment appeared to lead to a higher reduction in spasticity in the affected arm; however, it did not provide additional changes in functionality, pain and quality of life. Further studies with a randomised controlled trial design are required to confirm our findings. PMID: 32815384 [PubMed - as supplied by publisher]
Source: Acupuncture in Medicine : journal of the British Medical Acupuncture Society - August 19, 2020 Category: Complementary Medicine Authors: Cuenca Zaldívar JN, Calvo S, Bravo-Esteban E, Oliva Ruiz P, Santi-Cano MJ, Herrero P Tags: Acupunct Med Source Type: research

Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China
ConclusionsEarlier treatment of acute ischemic stroke patients with EVT in China increases lifetime QALYs and the economic value of care without any net increase in lifetime costs. Thus, healthcare policies should aim to improve efficiency of pre-hospital and in-hospital workflow processes to reduce the onset-to-puncture duration in China.
Source: Health Economics Review - January 6, 2022 Category: International Medicine & Public Health Source Type: research

Impact of NP follow-up calls on reducing 30-day readmissions in patients with stroke
Abstract: Hospital readmissions are major contributors to increased healthcare costs and lower quality of life. Despite advanced stroke care, patients who have experienced a stroke require ongoing follow-up care to prevent complications and hospital readmissions. We evaluated the impact of NP follow-up calls, providing another level of expertise to promptly identify new symptoms and complications, on readmission rates in patients who have experienced stroke.
Source: The Nurse Practitioner - May 1, 2022 Category: Nursing Tags: Feature: QUALITY IMPROVEMENT Source Type: research

An Updated Cost-Effectiveness Analysis (CEA) of r-tPA for Acute Ischemic Stroke (AIS) Treated Within 3 Hours of Symptom Onset (P4.243)
CONCLUSIONS: Economic analyses suggest that r-tPA is highly cost-effective in treatment of AIS across numerous efficacy, safety, and mortality estimates. Further research on differences in long-term mortality in disabled and non-disabled patients is needed.Study Supported by: Genentech Inc.Disclosure: Dr. Boudreau has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received research support from Genentech, Inc. Dr. Tayama has received personal compensation for activities with Genentech Inc. Dr. Tayam ho...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Boudreau, D., Guzauskas, G., Tayama, D., Fagan, S., Veenstra, D. Tags: Cerebrovascular Disease and Interventional Neurology: Endovascular Neurology Source Type: research

Medicare beneficiary out-of-pocket spending for stroke prevention in non-valvular Atrial Fibrillation: a budget analysis
Healthcare costs today are increasingly being shifted from payers to patients, yet few providers factor patient costs into treatment decisions. Recent advancements in stroke prevention in atrial fibrillation (AF) have resulted in new treatment options where previously there were few. While the clinical benefit and cost effectiveness of these treatments are supported by a growing body of evidence, the cost impact to patients has not been explored. This analysis sought to quantify patient out-of-pocket costs for three stroke prevention strategies: warfarin, dabigatran and left atrial appendage closure (LAAC) with the Watchman Device.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: S. Armstrong, S.L. Amorosi, G. Erickson, P. Patel, K. Stein Source Type: research

Does touch massage facilitate recovery after stroke? A study protocol of a randomized controlled trial
Despite high quality stroke care, decreased sensorimotor function, anxiety and pain often remain one year after stroke which can lead to impaired health and dependence, as well as higher healthcare costs. Touc...
Source: BMC Complementary and Alternative Medicine - February 4, 2016 Category: Complementary Medicine Authors: Kristina Lämås, Charlotte Häger, Lenita Lindgren, Per Wester and Christine Brulin Source Type: research

First year post-stroke healthcare costs and fall-status among those discharged to the community - Walsh ME, Sorensen J, Galvin R, Williams DJ, Harbison JA, Murphy S, Collins R, McCabe DJ, Crowe M, Horgan NF.
INTRODUCTION: Falls are common post-stroke events but their relationship with healthcare costs is unclear. The aim of this study was to examine the relationship between healthcare costs in the first year after stroke and falls among survivors discharged to...
Source: SafetyLit - April 26, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Cost-Effectiveness of Low-Dose Compared to Standard-Dose Alteplase for Acute Ischemic Stroke in China: A Within-Trial Economic Evaluation of the ENCHANTED Study
Conclusions: This health economic evaluation alongside the ENCHANTED indicates that the use of low-dose alteplase does not save overall healthcare costs nor lead to a gain in QALYs in the management of Chinese patients with AIS compared to the use of standard dose. There is little justification on economic grounds to shift from standard-of-care thrombolysis in AIS.Cerebrovasc Dis
Source: Cerebrovascular Diseases - August 31, 2022 Category: Neurology Source Type: research

Sensors, Vol. 22, Pages 6708: Investigating Stroke Effects on Respiratory Parameters Using a Wearable Device: A Pilot Study on Hemiplegic Patients
This study investigates the performance of a custom wearable device for respiratory monitoring in post-stroke patients. We tested the device on six hemiplegic patients under different respiratory regimes. The estimated respiratory parameters (i.e., respiratory frequency and the timing of the respiratory phase) demonstrated good agreement with the ones provided by a gold standard device. The promising results of this pilot study encourage the exploitation of wearables on these patients that may strongly impact the treatment of chronic diseases, such as hemiplegia.
Source: Sensors - September 5, 2022 Category: Biotechnology Authors: Joshua Di Di Tocco Daniela Lo Presti Martina Zaltieri Marco Bravi Michelangelo Morrone Silvia Sterzi Emiliano Schena Carlo Massaroni Tags: Article Source Type: research

P35 Economic Benefit of Stroke Technology-Assisted Rehabilitation (STAR): A Scoping Review
High-intensity rehabilitation is an evidence-based effective treatment for reducing disability and improving the quality of life in stroke survivors with sensorimotor impairments. Increasing healthcare costs, rising demand for rehabilitative treatment, and a shortage of healthcare professionals have motivated the development of new technologies to support high-intensity stroke rehabilitation more effectively. However, relatively little data is available regarding the economic benefits of these new approaches, including virtual reality, exoskeletons, robots, and wearable sensors.
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: T. Samkharadze, H.J. Cheng, S. Kager, K.S.G. Chua, O. Lambercy, N. Wenderoth Source Type: research

Nearly one in 25 will have a stroke, costs to double by 2030
CHARLESTON, S.C., May 27 (UPI) -- U.S. healthcare costs to treat stroke are forecast to more than double and the number of people having strokes may increase 20 percent by 2030, researchers say.
Source: Health News - UPI.com - May 27, 2013 Category: Consumer Health News Source Type: news

Abstract 242: Healthcare Resource Utilization and Costs among Patients with Non-Valvular Atrial Fibrillation using Dabigatran or Warfarin For Stroke Prevention Session Title: Poster Session II
Conclusions: Although newly diagnosed, newly treated NVAF patients initiated on dabigatran had higher pharmacy costs than those on warfarin, the total healthcare costs were similar between the two cohorts. In addition, fewer office visits were observed in the dabigatran cohort.
Source: Circulation: Cardiovascular Quality and Outcomes - June 2, 2014 Category: Cardiology Authors: Fu, A.-C., Jain, R., Sander, S. D., Lim, J., Jain, G., Yu, Y., Tan, H. Tags: Session Title: Poster Session II Source Type: research